C

Caidya

Global CRO delivering end-to-end clinical development

Investigator Contracts Lead - Insourced to MNC

Full-TimeUpdated on 10/20/2026
No salary listed
Mid
Bachelor's, Master's, JD
China
In Person
Contract Management

About the job

Requirements
  • A BA/BS degree in a related field is required.
  • At least 3 years of contracts-related experience is required.
  • A strong understanding of contracting principles and requirements is required.
  • Familiarity with budget development, benchmarking practices, and fair market value principles is required.
  • Proficiency in general and regionally specific contract fundamentals, applied to contract drafting, review, negotiation, and amendment processes is required.
  • A good understanding of clinical trial processes across Phases II–IV and ICH GCP is required.
  • Proficiency with Windows, Microsoft Word, Excel, and PowerPoint is required.
  • Exceptional written and oral English communication skills are required.
Responsibilities
  • Act as Contract Lead for assigned countries and regions, participate in kick-off meetings and sponsor calls, provide procedural and legal guidance, and advise on how to expedite and facilitate site contract execution.
  • Forecast intermediate Clinical Contracts steps and oversee execution to achieve contractual milestones.
  • Manage Contracts Specialists and other staff negotiating site contracts, and ensure they have access to applicable study-specific systems and folders, including Egnyte, D365, eTMF, and the study startup system.
  • Create study-specific contract templates for assigned countries, either by drafting them directly or collaborating with assigned contract negotiators.
  • Work with the Project Manager and Sponsor to develop contract negotiation guidelines and parameters, escalation pathways, and sponsor-specific signature requirements.
  • Work with the Project Manager, Grants Administration, Sponsor, and local Country Experts to develop country-specific site budget templates, negotiation benchmarks, escalation procedures, and fair market value assessment pathways.
  • Forecast site contract execution dates and communicate timelines to stakeholders; oversee site contract and budget status entries in applicable tracking systems.
  • Collaborate with contract negotiators to resolve site contract and budget impasses, including negotiating directly with study sites when appropriate.
  • Conduct fair market value assessments for budget items outside negotiation benchmarks and facilitate Sponsor approval or provide direct approval when authorized.
  • Serve as an internal escalation point to resolve legal-language negotiations, including approving contract terms when authorized.
  • Maintain and update country-specific contract templates in the Clinical Contracts CTA template repository.
  • Support development and creation of contracts-related departmental intelligence tools.
  • Mentor Clinical Contracts team members on complex contract issues.
  • Serve as a contracts subject matter expert within the department and across departments.
  • Conduct trainings when called upon.
Desired Qualifications
  • An advanced degree is preferred.
  • Legal education, such as Paralegal certification or a Juris Doctor, is preferred.
  • Clinical research, contracts, or related experience in a team-oriented environment is preferred; experience in a CRO or pharmaceutical setting is strongly preferred.
  • Experience with industry benchmarking tools such as GrantPlan or GrantsManager is an advantage.
  • Proficiency in another language is an advantage.

About the company

Caidya is a global contract research organization that provides outsourced clinical development services for biopharmaceutical and medical device companies. It covers the full lifecycle from pre-IND strategy and early-phase development through late-stage trials, regulatory submissions, and post-marketing surveillance, delivered via flexible models like standalone projects, full-service partnerships, and functional service provider arrangements, supported by its Clarity data platform that offers near real-time trial visibility and compatibility with Medidata Rave and Veeva. Its competitive edge comes from the merged legacy of Clinipace and dMed Global, strong leadership under Dr. Lingshi Tan, a broad global footprint including North America and China, and an emphasis on data-driven, transparent trial delivery. The goal is to help clients bring therapies to market efficiently and compliantly through high-quality, scalable trial execution across global programs.

Company Size

201-500

Company Stage

Growth Equity (Non-Venture Capital)

Total Funding

$322.2M

Headquarters

Morrisville, North Carolina

Founded

2003

Get referred to Caidya

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 2026 NMPA accepted partner MediLink's Tam-Peli NDA, validating China execution.
  • Caidya’s APAC-heavy model fits sponsors needing China speed and regulatory navigation.
  • Rubicon’s $165 million 2025 growth capital still funds expansion and integration.

What critics are saying

  • Combining Caidya and Simbec-Orion creates integration failure risk through 2026-2027.
  • CRO rivals Fortrea, ICON, and Medpace outspend Caidya on scale and technology.
  • Failed integration traps Caidya as a subscale CRO and forces retrenchment.

What makes Caidya unique

  • June 30, 2026 deal with Simbec-Orion adds Phase I clinical pharmacology to Caidya.
  • Barbara Lopez Kunz now runs a CRO spanning Europe, Americas, APAC, and China.
  • Michael Clay’s February 2026 COO hire deepens global delivery across 60 countries.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

-1%
Business Wire
Jul 1st, 2026
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution....

Associated Press
Feb 17th, 2026
Caidya appoints Michael Clay as COO to strengthen global clinical trial operations across Asia-Pacific

Caidya, a global clinical research organisation, has appointed Michael Clay as chief operating officer. Clay will oversee global operational delivery, client engagement and execution strategy across the US, Europe and Asia-Pacific. Clay brings extensive experience leading global clinical programmes across more than 60 countries, with particular expertise in Asia-Pacific operations. Most recently, he served as senior vice president of Global Project Delivery at Fortrea, where he managed over 500 global clinical trials. The appointment strengthens Caidya's operational capabilities, particularly in China and the broader APAC region. Caidya operates in more than 20 countries and conducts studies across over 50 countries, focusing on complex therapeutic areas including oncology, haematology and rare diseases.

Business Wire
Jan 16th, 2025
Caidya Announces $165 Million Strategic Growth Investment From Rubicon Founders

Caidya today announced the closing of a strategic growth investment of $165 million from funds managed by Rubicon Founders.

Business Wire
Jan 13th, 2025
Caidya Announces $165 Million Strategic Growth Investment From Rubicon Founders

Caidya announces $165 million strategic growth investment from Rubicon Founders.

FinSMEs
Jul 10th, 2021
dMed-Clinipace Closes US$50M Series C+ Financing

dMed-Clinipace, a Shangai, China- and Morrisville, NC-based global full-service Clinical Contract Research Organization (CRO), closed a US$50m Series C+ financing. The round was led by Springhill Fund, with participation from funds managed by Rock Springs Capital and Superstring Capital. They joined Series C lead investor Fidelity Management and Research Company LLC as well as other new […]